KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Asset Utilization Ratio (2016 - 2025)

Pacific Biosciences Of California (PACB) has 15 years of Asset Utilization Ratio data on record, last reported at 0.2 in Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 77.41% year-over-year to 0.2; the TTM value through Dec 2025 reached 0.2, up 77.41%, while the annual FY2025 figure was 0.16, 52.77% up from the prior year.
  • Asset Utilization Ratio reached 0.2 in Q4 2025 per PACB's latest filing, up from 0.19 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.2 in Q4 2025 and bottomed at 0.06 in Q4 2021.
  • Average Asset Utilization Ratio over 5 years is 0.11, with a median of 0.1 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: crashed 76.99% in 2021, then surged 77.41% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.06 in 2021, then grew by 10.78% to 0.07 in 2022, then skyrocketed by 53.78% to 0.11 in 2023, then grew by 3.27% to 0.11 in 2024, then skyrocketed by 77.41% to 0.2 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.2 in Q4 2025, 0.19 in Q3 2025, and 0.19 in Q2 2025.